💡 Key Takeaways
Table of Contents
Sulforaphane is associated with broccoli, sprouts, and the Nrf2 pathway. It also appears in very different headlines: some cautious, others clearly exaggerated. This article separates three things that are often mixed up: what sulforaphane is, how it is formed, and what has actually been observed in human studies.
A compound that doesn't exist until we activate it
Sulforaphane is a sulfurized isothiocyanate produced in vegetables of the Brassicaceae family: broccoli, kale, collard greens, radish, watercress. Its peculiarity is that it is not present in the intact plant. It exists in a latent form as glucoraphanin, an inactive glucosinolate stored in cellular vacuoles.
Glucoraphanin and myrosinase—the enzyme that transforms it—are stored in separate compartments within the same cell. This is a defense mechanism: when something punctures the plant tissue, the two compounds come into contact and the reaction is triggered. In the field, this damage is caused by an insect. In the kitchen, we cause it by cutting or chewing.
Without that physical damage, there is no sulforaphane.
How sulforaphane is formed: glucoraphanin, myrosinase, and chewing
The conversion follows three steps: plant tissue receives physical damage—cutting, chewing, crushing—, the released myrosinase comes into contact with glucoraphanin, and, within minutes, hydrolyzes it to produce active sulforaphane.
The reaction is fast, but the enzyme is fragile. Myrosinase is inactivated above approximately 70 °C. Boiling broccoli for more than three or four minutes destroys virtually all enzyme activity. A study by Vermeulen et al. in Molecular Nutrition & Food Research (2008) measured the bioavailability of sulforaphane in people with raw versus cooked broccoli: availability was significantly higher with raw or barely blanched vegetables.
Mustard offers a partial alternative for cooked broccoli. It contains its own active myrosinase, which can partially compensate for enzyme loss. The effect is experimentally supported, although the amount of enzyme it provides varies depending on the type and quantity used.
When myrosinase is unavailable—due to cooking, industrial processing, or absence in supplements—conversion can partially occur through the gut microbiota. The problem is variability: the ability of each microbiome to hydrolyze glucosinolates differs among individuals. Two individuals taking the same glucoraphanin supplement can end up with very different levels of circulating sulforaphane.
Where it is found: sources and actual concentrations
Glucoraphanin is present in all cruciferous vegetables, but in very different concentrations. Broccoli is the most studied source and has the highest documented content.
| Source | Glucoraphanin (approx.) | Reference |
|---|---|---|
| Mature broccoli | 0.1–2.2 µmol/g fresh weight | Kushad et al., 1999 |
| Broccoli sprouts (3–5 days) | 10–100× more than mature broccoli | Fahey et al., PNAS 1997 |
| Broccoli microgreens (7–14 days) | High concentration, variable depending on cultivation | Bouranis et al., Foods 2023 |
| Kale | Present, lower than broccoli | — |
| Brussels sprouts | Present, moderate concentration | — |
| Radish | Present, mainly in root and leaves | — |
| Watercress | Present (predominant isothiocyanate: PEITC, different from sulforaphane) | — |
Variability within the same species is considerable. Kushad et al. (1999) analyzed 50 commercial broccoli varieties and found differences of up to 27 times between the poorest and the richest in glucoraphanin. Cultivation method, season, post-harvest storage, and time since harvest also affect the final content.
→ Detailed reading on this variability: Glucoraphanin in broccoli: variety, cultivation and actual concentration
→ Why cruciferous vegetables occupy their own category: Why cruciferous vegetables are different from other vegetables
How it acts in the body: the Nrf2 pathway
Once absorbed in the small intestine, sulforaphane reaches cells and activates the Nrf2 (Nuclear factor erythroid 2-related factor 2) pathway. Under normal conditions, Nrf2 remains sequestered in the cytoplasm, bound to the Keap1 protein. Sulforaphane modifies cysteine residues in Keap1, which releases Nrf2 and allows it to move to the cell nucleus.
Inside the nucleus, Nrf2 binds to antioxidant response elements (ARE) in the DNA and activates the transcription of more than 200 genes. Among them:
Phase II detoxification enzymes: glutathione S-transferases (GST), quinone oxidoreductase (NQO1), thioredoxin reductase.
γ-glutamylcysteine synthetase (GCLC), the rate-limiting step in glutathione production.
Heme oxygenase-1 (HO-1), with documented anti-inflammatory and cytoprotective effects.
Sulforaphane does not directly trap free radicals. What it does is induce the enzymatic systems that are responsible for it. Direct antioxidants have a punctual effect; Nrf2 inducers generate a sustained response for hours or days.
What the research says: humans, animals, and in vitro
The volume of publications on sulforaphane exceeds 3,000 entries in PubMed. Not all this evidence carries the same weight, and separating the levels is necessary to understand what is truly known.
| Level of evidence | What has been observed | Limitations |
|---|---|---|
| In vitro (cells) | Activates Nrf2, inhibits NF-κB, induces apoptosis in tumor cell lines | The doses used are not replicable with food; results do not predict effects in humans |
| Animal | Effects on inflammation, neuroprotection, and glucose metabolism in murine models | Extrapolation to humans is limited; metabolism and bioavailability differ |
| Humans — observational | Cruciferous consumption associated with lower risk of some cancers in cohort studies | Association, not causality; results may be affected by other dietary habits |
| Humans — clinical trials | Effects on markers of oxidative stress, inflammation, and fasting glucose in several studies | Small samples (20–150 people), short duration (4–12 weeks), heterogeneity of doses and formats |
A systematic review by Bahadoran et al. in Nutrition Reviews (2021) on the effects of sulforaphane on metabolic biomarkers concludes that the data are promising, but insufficient to establish formal clinical recommendations. The variability in bioavailability among individuals is one of the main obstacles to interpreting the results.
The basic mechanisms are well established in vitro and in animals. Confirmation in humans is progressing, but requires larger and longer trials.
Why not everyone absorbs the same amount
The amount of sulforaphane that circulates in the blood after consuming a source of glucoraphanin depends on several factors.
Active myrosinase. When the enzyme has been destroyed by heat or industrial processing, conversion relies entirely on the gut microbiota. Studies with glucoraphanin supplements without myrosinase show plasma sulforaphane levels between 3 and 10 times lower than those obtained with sources that retain the enzyme (Clarke et al., Cancer Prevention Research, 2011).
Microbiota composition. The variability among individuals in the ability of intestinal flora to hydrolyze glucosinolates is wide. Some individuals convert more than 40% of ingested glucoraphanin; others, less than 10% (Fahey et al., PLOS ONE, 2015).
Intestinal transit. Rapid transit reduces the contact time between glucoraphanin and colon bacteria, decreasing the available conversion.
Physical form of the food. Chewing raw vegetables thoroughly maximizes myrosinase activation. An whole, uncrushed vegetable releases less than one that is well-chewed or cut.
→ How the food format changes actual absorption: Nutrient bioavailability: why do you absorb 5% of some supplements?
What the evidence does not allow us to say
Health claims for sulforaphane have been reviewed by the EFSA and have not been authorized in the EU claims register. This does not mean that the compound has no documented physiological effects. It means that the available evidence at the time of the review did not reach the required level: causality demonstrated in humans with a robust design.
Established in vitro and animal mechanisms: solid, well-replicated, published in high-impact journals.
Effects on human biomarkers: documented in several small trials, pending confirmation in larger studies.
Direct clinical benefits (disease prevention, mortality reduction): not demonstrated to the level required for a regulatory claim.
Scientific interest is justified. Headlines that go beyond the evidence are not.
How to obtain sulforaphane practically
The route with the best documented bioavailability is the consumption of raw or lightly cooked cruciferous vegetables, with sufficient chewing for myrosinase to act.
Experimentally supported strategies:
Cut broccoli 40 minutes before cooking. Myrosinase activates part of the conversion before heat. Once formed, sulforaphane is more thermostable than the enzyme that produces it.
Prefer short steaming or quick stir-frying. Steaming at moderate temperatures preserves more enzyme activity than boiling directly in water.
Add mustard to cooked broccoli. Provides active exogenous myrosinase that can partially compensate for loss during cooking.
Consume raw sprouts or microgreens. They concentrate glucoraphanin and retain active myrosinase without any thermal processing.
For those seeking a concentrated and stable source without relying on culinary preparation, low-temperature freeze-dried microgreens preserve both glucoraphanin and myrosinase in their original plant matrix. Freeze-drying removes water without destructive heat, maintaining intact enzymatic conversion capacity. This is what differentiates SYNERGIC from an industrialized extract: the precursor and the enzyme remain in their biological context, available for activation in contact with saliva and the digestive environment.
→ Why the food form changes what the body absorbs: Sulforaphane: what it is, how it works, and why its whole food form is superior
Frequently asked questions
Is sulforaphane already present in broccoli?
No. Broccoli contains glucoraphanin, its inactive precursor. Sulforaphane is formed when the plant tissue is damaged—by cutting, chewing, or crushing—and myrosinase comes into contact with glucoraphanin. An intact plant does not contain active sulforaphane.
What is the difference between glucoraphanin and sulforaphane?
Glucoraphanin is the precursor glucosinolate stored in the plant; it is inactive. Sulforaphane is the active isothiocyanate that forms from it through the action of myrosinase. Without that active enzyme—either in the vegetable or in the intestine—conversion is partial or does not occur.
Does cooking destroy sulforaphane?
It does not destroy already formed sulforaphane, but it inactivates myrosinase before it can act. If broccoli is cooked without having been cut beforehand, most of the glucoraphanin reaches the intestine without being converted. Cutting broccoli 40 minutes before cooking allows some of the conversion to occur beforehand.
How much sulforaphane is in broccoli?
It depends on the variety, cultivation method, and processing. An analysis of 50 commercial varieties found differences of up to 27 times in glucoraphanin content between the poorest and richest (Kushad et al., 1999). Boiled broccoli provides significantly less available sulforaphane than raw.
What does research say about sulforaphane in humans?
Several clinical trials document effects on biomarkers of oxidative stress, inflammation, and fasting glucose. The studies are promising, but mostly small (20–150 people) and short-term (4–12 weeks). Health claims have not been authorized by the EFSA.
Are sulforaphane supplements safe?
At doses equivalent to those in food, no significant adverse effects have been reported. With concentrated supplements, some people report mild digestive discomfort. Those with hypothyroidism or taking medication that affects liver metabolism should consult a professional before supplementing.
Conclusion
Sulforaphane is a biochemically well-characterized compound. Its formation mechanism—glucoraphanin plus active myrosinase—explains why food preparation radically changes the available amount, and why the variability among individuals in circulating levels is so high.
Research in humans is promising. Biomarker studies show effects on oxidative stress, inflammation, and fasting glucose. But most are small and short-term, and have not reached the level of evidence required for a regulatory claim. This does not diminish the scientific interest in the compound; it simply places the discussion in its proper context.
The practical issue is the same as with any other nutrient: the dose that circulates depends as much on the source as on processing and the individual. Well-constructed nutrition considers both factors.
